You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

5389 Results
Drug
Other Name(s): Xpovio®
Quick Link(s): Drug Monograph, Patient Info Sheet
Mar 2024
Document
Feb 2024
Document
Feb 2024
Document
Feb 2024
Document
Feb 2024
Document
Feb 2024
Document
Feb 2024
Guidelines and Advice
Status: Current
ID: GL 19-7
Mar 2024
Drug
Other Name(s): Brukinsa®
Quick Link(s): Drug Monograph, Patient Info Sheet
Apr 2024
Document
Mar 2024
Regimen
Cancer Type:
Endocrine, 
Thyroid
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
Exceptional Access Program
    cabozantinib - For the treatment of adult patients with locally advanced or metastatic differentiated thyroid carcinoma that has progressed following prior VEGFR-targeted therapy and who are radioactive iodine-refractory or ineligible
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
cabozantinib (tablet)
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Dec 2024
Document
Mar 2024

Pages